IRADIMED CORPORATION Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- IRADIMED CORPORATION stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $3.30K, a 55.09% decline year-over-year.
- IRADIMED CORPORATION stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $7.34K.
- IRADIMED CORPORATION stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $74.76K, a 18.82% increase year-over-year.
- IRADIMED CORPORATION stock issued during period, value, stock options exercised for the quarter ending 2022-03-31 was $71.95K, a 2824.72% increase year-over-year.
- IRADIMED CORPORATION stock issued during period, value, stock options exercised for fiscal 2024 was $30.00K, a 83.03% decline from fiscal 2023.
- IRADIMED CORPORATION stock issued during period, value, stock options exercised for fiscal 2023 was $176.74K, a 20.47% increase from fiscal 2022.
- IRADIMED CORPORATION stock issued during period, value, stock options exercised for fiscal 2022 was $146.71K, a 76.46% decline from fiscal 2021.
- IRADIMED CORPORATION stock issued during period, value, stock options exercised for fiscal 2021 was $623.24K, a 63.98% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $30.00K 10-K · filed 2026-03-06 | |
| 2024-06-30 | $3.30K 10-Q · filed 2025-11-03 | |
| 2023-12-31 | $176.74K 10-K/A · filed 2025-09-03 | |
| 2023-06-30 | $7.34K 10-Q · filed 2024-10-31 | |
| 2022-12-31 | $146.71K 10-K · filed 2024-03-01 | |
| 2022-09-30 | $74.76K 10-Q · filed 2023-11-03 | |
| 2022-03-31 | $71.95K 10-Q · filed 2023-11-03 | |
| 2021-12-31 | $623.24K 10-K · filed 2023-03-02 | |
| 2021-09-30 | $62.92K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $20.23K 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $2.46K 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $1.73M 10-K · filed 2022-03-04 | |
| 2020-09-30 | $931.73K 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $468.81K 10-Q · filed 2021-11-05 | |
| 2020-03-31 | $322.18K 10-Q · filed 2021-11-05 | |
| 2019-09-30 | $1.71M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $43.51K 10-Q · filed 2020-11-06 | |
| 2019-03-31 | $456.74K 10-Q · filed 2020-11-06 | |
| 2018-03-31 | $95.92K 10-Q · filed 2019-05-08 | |
| 2015-12-31 | $597.51K 10-K · filed 2016-03-10 | |
| 2014-12-31 | $105.00K 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |